Literature DB >> 9392542

Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging.

D F Dubois1, B R Prestidge, L A Hotchkiss, W S Bice, J J Prete.   

Abstract

PURPOSE: Dosimetric evaluation of completed brachytherapy implant procedures is crucial in developing proper technique and has prognostic implications. Accurate definition of the prostate gland and localization of the implanted radioactive sources are critical to attain meaningful dosimetric data. Methods using radiographs and CT accurately localize sources, but poorly delineate the prostate gland. MRI has been recognized as a superior imaging modality in delineating the prostate gland, but poor in localizing sources due to lack of source visibility. The purpose of this study was to optimize the visualization of sources using MRI and compare to CT derived source localization. METHODS AND MATERIALS: Multiple MRI scanning techniques were attempted until an acceptable sequence to visualize both the prostate gland and the implanted sources was found. The exams were performed using a pelvic coil only in approximately 15 min. The CT and MRI scans of 20 consecutive patients who had received TRUS-guided permanent transperineal interstitial prostate 125Iodine or 103Palladium brachytherapy were evaluated using an in-house dosimetry system. To eliminate anatomical dependence, the MRI-derived DVHs for the entire calculation volume were then compared to those derived from the CT scans.
RESULTS: The differences in isodose volumes, of the calculation volumes, for all implants at all dose levels were not statistically significant at the 95% confidence level. Calculation volume isodose volumes derived from MR images were statistically similar to those derived from CT images at the prescription dose for both 125Iodine (p < 0.01) and 103Palladium (p < 0.026).
CONCLUSION: This study presents the first evidence that MRI may be reliably used to identify permanently implanted 125Iodine and 103Palladium sources. Given the advantage of target definition characteristics of MRI, substantially more accurate dosimetric analysis of prostate implants is now possible. The cost of the optimized and abbreviated MR scanning sequence used in this study is comparable to a pelvic CT scan. Postimplant MRI allows more accurate volumetric and anatomically relevant evaluation of permanent prostate implants, which may provide useful clinical correlation.

Entities:  

Mesh:

Year:  1997        PMID: 9392542     DOI: 10.1016/s0360-3016(97)00501-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.

Authors:  Tze Yee Lim; Rajat J Kudchadker; Jihong Wang; R Jason Stafford; Christopher MacLellan; Arvind Rao; Geoffrey S Ibbott; Steven J Frank
Journal:  Med Phys       Date:  2016-07       Impact factor: 4.071

2.  MRI-BASED PROSTATE BRACHYTHERAPY SEED LOCALIZATION.

Authors:  Nathanael Kuo; Junghoon Lee; Clare Tempany; Matthias Stuber; Jerry Prince
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2010-04-14

Review 3.  Permanent interstitial brachytherapy for prostate cancer: a current review.

Authors:  Jeffrey Woolsey; Nicole Miller; Dan Theodorescu
Journal:  World J Urol       Date:  2003-08-13       Impact factor: 4.226

Review 4.  Image fusion techniques in permanent seed implantation.

Authors:  Alfredo Polo
Journal:  J Contemp Brachytherapy       Date:  2010-10-13

5.  Post-implant computed tomography-magnetic resonance prostate image registration using feature line parallelization and normalized mutual information.

Authors:  Sandra Vidakovic; Hans S Jans; Abe Alexander; Ron S Sloboda
Journal:  J Appl Clin Med Phys       Date:  2006-07-05       Impact factor: 2.102

6.  Reactive Oxygen Species Generation in Human Cells by a Novel Magnetic Resonance Imaging Contrast Agent.

Authors:  Li Wang; Eric Lin; Mary J Johansen; Timothy Madden; Edward Felix; Karen S Martirosyan; Steven J Frank
Journal:  J Toxicol       Date:  2018-03-26

7.  Automated estimation of number of implanted iodine-125 seeds for prostate brachytherapy based on two-view analysis of pelvic radiographs.

Authors:  Hidemichi Kawata; Hidetaka Arimura; Hiroaki Suefuji; Sunao Ohkura; Yoshifumi Saida; Kazutaka Nashiki; Kazuya Hayashida; Tomomi Kawahara; Ayumu Ohishi; Naofumi Hayabuchi
Journal:  J Radiat Res       Date:  2012-07-05       Impact factor: 2.724

8.  A magnetic resonance-based seed localization method for I-125 prostate implants.

Authors:  Rena J Lee; Hyun Suk Suh; Kyung Ja Lee; Soome Lim; Yookyung Kim; Sungkyu Kim; Jinho Choi
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

9.  Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience.

Authors:  Tze Yee Lim; Rajat J Kudchadker; Jihong Wang; Tharakeswara Bathala; Janio Szklaruk; Thomas J Pugh; Usama Mahmood; Geoffrey S Ibbott; Steven J Frank
Journal:  J Contemp Brachytherapy       Date:  2016-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.